Palisade Bio, Inc. short interest in 2019
In 2019, Palisade Bio, Inc.'s disclosed short interest ran from 1.06% of shares outstanding on 15 Jan 2019 to 0.79% on 31 Oct 2019, a change of -0.27 percentage points. The year's high was 1.81% on 15 Jul 2019 and its low 0.55% on 13 Sep 2019, averaging 1.14% across 19 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 3.54 days on 15 Jul 2019. Full history: Palisade Bio, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2025 · 2026
2019 in figures
- Start of year
- 1.06% (15 Jan 2019)
- End of year
- 0.79% (31 Oct 2019)
- Change
- -0.27 pp
- High
- 1.81% (15 Jul 2019)
- Low
- 0.55% (13 Sep 2019)
- Average
- 1.14%
- Highest days to cover
- 3.54 (15 Jul 2019)
- SEC filings marked
- 8
Every report in 2019
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2019 | 1.06% | 1.18 | |
| 31 Jan 2019 | 1.70% | 1.00 | |
| 15 Feb 2019 | 1.52% | 2.00 | |
| 28 Feb 2019 | 1.23% | 1.00 | |
| 15 Mar 2019 | 1.14% | 1.06 | |
| 29 Mar 2019 | 0.83% | 1.00 | 10-K filed, results (8-K) |
| 15 Apr 2019 | 0.69% | 1.00 | |
| 30 Apr 2019 | 1.66% | 1.33 | |
| 15 May 2019 | 1.18% | 1.66 | 10-Q filed, results (8-K) |
| 31 May 2019 | 1.20% | 3.15 | |
| 14 Jun 2019 | 0.85% | 1.66 | |
| 28 Jun 2019 | 1.40% | 1.16 | |
| 15 Jul 2019 | 1.81% | 3.54 | |
| 15 Aug 2019 | 1.34% | 1.00 | 10-Q filed, results (8-K) |
| 30 Aug 2019 | 0.85% | 1.00 | |
| 13 Sep 2019 | 0.55% | 1.00 | |
| 30 Sep 2019 | 1.12% | 1.00 | |
| 15 Oct 2019 | 0.83% | 1.00 | |
| 31 Oct 2019 | 0.79% | 1.00 |
See also: Palisade Bio, Inc.'s full history · most shorted US stocks of 2019 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.